The global enteric softgel capsules market was valued at USD 2.75 billion in 2025. The market is projected to grow from USD 2.91 billion in 2026 to USD 4.99 billion by 2034, exhibiting a compound annual growth rate of 6.98% during the forecast period. Contrive Datum Insights presents this information in its report titled "Enteric Softgel Capsules Market Size, Share & Industry Analysis, By Type (Gelatin Type, Vegetable Type), Application (Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Cold, Cough and Analgesic Preparations, Others), End user (Pharmaceutical Manufacturers, Nutraceutical and Dietary Supplement Companies, Contract Manufacturing Organizations), Distribution channel (Direct/Institutional Sales, Retail Pharmacies and Drug Stores, Online Retail), Manufacturing technology (Rotary Die Encapsulation, Seamless Encapsulation), and Regional Forecast, 2026-2034".
Enteric softgel capsules are a soft-shell capsule format coated or formulated so that the fill dissolves only after passing through the stomach, protecting acid-sensitive active ingredients or shielding the stomach lining from irritating compounds. They are used to deliver pharmaceutical actives such as antacids, antibiotics and cardiovascular drugs as well as nutraceutical ingredients like probiotics, enzymes and certain vitamins. Buyers are pharmaceutical manufacturers, dietary-supplement and nutraceutical brands, and the contract encapsulation and fill-finish operations that produce softgels on their behalf.
Growing use of enteric softgels in gut-targeted nutraceuticals
Growing use of enteric softgels in gut-targeted nutraceuticals is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 6.98% a year, the type lines exposed to it move fastest: Vegetable Type compounds at 10.28%, taking its share of revenue from 32% to 42.1% and its value from USD 0.88 billion to USD 2.1 billion.
On the upside, the study's bull case assumes faster adoption of enteric softgel formats by dietary-supplement brands and quicker capacity additions at contract encapsulation facilities in Asia Pacific lift volumes above the base case, which would take 2034 revenue to USD 5.66 billion rather than the USD 4.99 billion base case.
However, slower supplement-brand adoption and continued raw-material cost pressure on gelatin and specialty polymers hold volumes below the base case, which would hold 2034 revenue to USD 4.44 billion. Gelatin Type, which carries 68% of 2025 revenue, already grows at only 5.04% against the market's 6.98%, so the largest part of the base is also its slowest.
Key Players Compete on Gelatin Type Volume and Vegetable Type Growth
Competition in the global enteric softgel capsules market runs along the type axis rather than the regional one. Gelatin Type holds 68% of 2025 revenue at USD 1.87 billion and remains the largest line through 2034 at 57.9%, making it the position hardest for a challenger to take. Vegetable Type, growing at 10.28%, is where share actually changes hands. A supplier established in one is not thereby established in the other, which is what sustains a field of this size in a market of USD 2.75 billion.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Type | Gelatin Type | 68% · USD 1.87 billion | — |
| Application | Antacid and Antiflatulent Preparations | 34.2% · USD 0.94 billion | Vitamins and Dietary Supplements 9.55% |
| End user | Pharmaceutical Manufacturers | 46.2% · USD 1.27 billion | Nutraceutical and Dietary Supplement Companies 8.54% |
| Distribution channel | Direct/Institutional Sales | 58.2% · USD 1.6 billion | Online Retail 13.5% |
| Manufacturing technology | Rotary Die Encapsulation | 81.8% · USD 2.25 billion | Seamless Encapsulation 10.21% |
- Based on regional analysis, Asia Pacific led the global enteric softgel capsules market in 2025 with 34.2% of global revenue at USD 0.94 billion, reaching USD 1.9 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 34.2% in 2025 to 38.1% in 2034, with revenue growing from USD 0.94 billion to USD 1.9 billion.
- Middle East and Africa remains the smallest region throughout, at 4.7% of 2025 revenue and 4.8% by 2034.
- Vegetable Type is projected to grow at 10.28% over the forecast period, the fastest of any type line.
- The United States is the largest single country market at USD 0.68 billion in 2025, 24.7% of global revenue.
The report segments the market across five axes; by type, and by application, end user, distribution channel and manufacturing technology; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 4.44 billion and USD 5.66 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.